Both autologous and allogeneic transplants have been extensively studied in the management of non-Hodgkin's lymphomas and may offer a chance of a long-term cure for some patients. Autologous stem cell transplantation is considered standard therapy for patients with diffuse large B cell lymphoma in ...
CAR T细胞在癌症治疗中的应用 CAR T细胞疗法最初是针对某些类型的血液肿瘤,特别是急性淋巴细胞性白血病(Acute Lymphoblastic Leukemia, ALL)和非霍奇金淋巴瘤(Non-Hodgkin Lymphoma, NHL)。这种疗法在一些临床试验中显示出非常有希望的结果。例如,在对于...
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. This study was conducted to compare the results of myeloablative therapy followed either by autologous stem cell transplantation (SCT) or allogeneic SCT fo... Verdonck,F Leo - 《Leu...
A., et al. (2016). Bispecific T-cell engager (BiTE) antibody construct Blinatumomab for the treatment of patients with relapsed/refractory non-Hodgkin lymphoma: final results from a Phase I study. J. Clin. Oncol. 34, 1104–
Weaver C H, Schwartzberg L, Zhen B, et al. High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin slymphoma:results of outpatient treatment in community cancer centers[J].Bone Marrow Transplant,1997,20:753-760....
Stem cells are undifferentiated cells that, when given the right signal, can become any type of specialized cell Stem cells found in adults are known as adult stem cells, which normally act as a repair system for the body, constantly replenishing our body’s tissues. ...
doi:10.1080/10245332.2000.11746492BrunoGabrielaV.BallesterOscarF.Hematology
High dose therapy with or without hematopoietic stem cell rescue has been widely used in the past decade for treating aggressive Non-Hodgkin's lymphoma. Recent data in high and intermediate grade lymphoma were reviewed. Evidence that dose intensity is a critical factor for remission in poor prognos...
Objective:To evaluate the clinical efficacy and safety of autologous hematopoietic stem cell transplantation(AHSCT) for the aggressive T cell non-Hodgkin's lymphoma(T-NHL).Method:We reported and analyzed 28 patients with aggressive T-NHL retrospectively.The first conditioning regimen was 19 of IEP ...
several investigations have demonstrated that KIR haplotypes predict the prognosis and the conversion of MDS to AML47; the incidence of leukemia48and solid tumors49; the prognosis of classical Hodgkin’s lymphoma50; the prognosis and response to targeted therapies in colorectal cancer51,52; and the...